Operational impact of COVID-19

Friday 21 August 2020    

The impact of COVID-19 on Recipharm’s worldwide operations is constantly monitored and regular updates provided on www.recipharm.com

We are pleased to report that currently, our operations are largely functioning in a normal manner albeit with enhanced safety procedures and adapted working practices.

Recipharm’s response to COVID-19

We are investing significant effort and resources to ensure continued supply to our customers and patients. Measures include adapting work schedules, shifts patterns and overtime work whilst putting non-manufacturing activities on hold for the time being. Other precautionary measures include a cessation of employee travel, supporting home working and enhancing health and safety procedures in the manufacturing facilities and laboratories.

Recipharm continues to follow all governmental recommendations whilst at the same time working to mitigate any disruptions. Our highest priority is always to ensure that we uphold our responsibilities to employees, customers, patients and partners. This means striving to deliver the highest quality of service whilst also focusing on the safety and well-being of our workforce and extended community. 

We are very grateful to our employees and partners who continue to willingly support our efforts to maintain operations and our supply chains. 

Contact information

Erik Haeffler, Vice President Manufacturing Services & Head of Sustainability, erik.haeffler@recipharm.com, + 46 8 602 52 85